Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pain medicine (Malden, Mass.)

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1526-4637.2007.00276.XPMID 17661854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Health State Preference Assessment in Diabetic Peripheral Neuropathy

  2012cited by this paper
• Duloxetine in the treatment of major depressive disorder

  2007cited by this paper
• A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

  2006cited by this paper
• Duloxetine vs. placebo in patients with painful diabetic neuropathy

  2005cited by this paper
• Preventing foot ulcers in patients with diabetes.

  2005cited by this paper
• Diabetic neuropathies: a statement by the American Diabetes Association.

  2005cited by this paper
• Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo‐controlled clinical trials

  2005cited by this paper
• Diabetic lower extremity infection: influence of physical, psychological, and social factors.

  2005cited by this paper
• A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

  2005cited by this paper
• Duloxetine in the Treatment of Depression: A Double-Blind Placebo-Controlled Comparison With Paroxetine

  2004cited by this paper
• Effects of duloxetine on painful physical symptoms associated with depression.

  2004cited by this paper
• Psychological aspects of diabetic neuropathic foot complications: an overview

  2004cited by this paper
• The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument.

  2003cited by this paper
• Controlled-release oxycodone for pain in diabetic neuropathy

  2003cited by this paper
• Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

  2003cited by this paper
• Understanding the impact of painful diabetic neuropathy

  2003cited by this paper
• Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression.

  2003cited by this paper
• SF-36 health survey: Manual and interpretation guide

  2003cited by this paper
• Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

  2002cited by this paper
• Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.

  2002cited by this paper
• Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

  2002cited by this paper
• Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy

  2002cited by this paper
• Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

  2002cited by this paper
• Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

  2002cited by this paper
• Potential mechanisms of neuropathic pain in diabetes.

  2002cited by this paper
• Duloxetine for the treatment of major depressive disorder.

  2002cited by this paper
• Psychological and Behavioural Issues in Diabetic Neuropathic Foot Ulceration

  2002cited by this paper
• Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

  2001cited by this paper
• Diabetic foot ulcers: a quality of life issue

  2001cited by this paper
• A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias

  2000cited by this paper
• SF-36 Health Survey Update

  2000cited by this paper
• Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life.

  2000cited by this paper
• Treatment options in painful diabetic neuropathy

  1999cited by this paper
• Preventive Foot Care in People With Diabetes

  1998cited by this paper
• Self-Rated Health and Diabetes of Long Duration: The Wisconsin Epidemiologic Study of Diabetic Retinopathy

  1998cited by this paper
• Pathophysiology and treatment of painful diabetic neuropathy of the lower extremity.

  1998cited by this paper
• The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

  1998cited by this paper
• Quality of Life and Associated Characteristics in a Large National Sample of Adults With Diabetes

  1997cited by this paper
• Levels and Risks of Depression and Anxiety Symptomatology Among Diabetic Adults

  1997cited by this paper
• The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010

  1997cited by this paper
• SF-36 physical and mental health summary scales : a user's manual

  1994cited by this paper
• Pain assessment: global use of the Brief Pain Inventory.

  1994cited by this paper
• The MOS 36-Item Short-Form Health Survey (SF-36)

  1992cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection

  1992cited by this paper
• EuroQol--a new facility for the measurement of health-related quality of life.

  1990cited by this paper
• EuroQol : a new facility for the measurement of health-related quality of life

  1990cited by this paper
• Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

  1989cited by this paper

• Quality of life in patients undergoing lung resection: Evaluation of outcomes of follow-up using brief pain inventory

  2025cites this paper
• Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis

  2024cites this paper
• A Review on Diabetic Peripheral Neuropathy

  2021cites this paper
• A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

  2020cites this paper
• Extensive selective reporting of quality of life in clinical study reports and publications of placebo-controlled trials of antidepressants

  2020cites this paper
• PSYCHOLOGY, PSYCHIATRY & BRAIN NEUROSCIENCE Original Research Articles Differences in Pain, Psychological Symptoms, and Gender Distribution among Patients with Left- vs Right-Sided Chronic Spinal Pain

  2017cites this paper
• A COMPREHENSIVE STUDY ON LITERATURE EVIDENCE, CLINICAL STUDIES AND PRACTICES OF HERBAL DRUGS FOR DIABETIC NEUROPATHY AND CARDIOMYOPATHY

  2017cites this paper
• Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure

  2015cites this paper
• Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain

  2015cites this paper
• From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy.

  2015cites this paper
• Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study

  2015cites this paper
• A retrospective descriptive study of pain scores in pre-diabetic patients on metformin

  2015cites this paper
• Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy

  2014cites this paper
• A Review of Duloxetine 60 mg Once‐Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain

  2013cites this paper
• Neuropathic Pain

  2013cites this paper
• Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain

  2012influential citation
• Antinociceptive Effects of Monoamine Reuptake Inhibitors in Assays of Pain-Stimulated and Pain-Depressed Behaviors

  2012cites this paper
• Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain

  2012cites this paper
• Clinical approach to the treatment of painful diabetic neuropathy

  2011cites this paper
• The use of the EQ‐5D preference‐based health status measure in adults with Type 2 diabetes mellitus

  2011cites this paper
• Neural Correlates of Chronic Low Back Pain Measured by Arterial Spin Labeling

  2011cites this paper
• Published norms underestimate the health-related quality of life among persons with type 2 diabetes.

  2011cites this paper
• Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine

  2010cites this paper
• Les douleurs neuropathiques chroniques: diagnostic, évaluation, traitement en médecine ambulatoire. Recommandation pour la pratique clinique de la Société Française d’étude et de Traitement de la Douleur

  2010cites this paper
• Les douleurs neuropathiques chroniques : diagnostic, évaluation et traitement en médecine ambulatoire. Recommandations pour la pratique clinique de la Société française d’étude et de traitement de la douleur

  2010cites this paper
• Chapter 26. Treatment of Neuropathic Pain

  2010cites this paper
• Inhibidores de la recaptación de serotonina y noradrenalina en el manejo del dolor de la neuropatía diabética

  2010cites this paper
• EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

  2010cites this paper
• EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision

  2010cites this paper
• Psychopathology predicts the outcome of medial branch blocks with corticosteroid for chronic axial low back or cervical pain: a prospective cohort study

  2009cites this paper
• Adjuvant analgesics in neurop athic pain

  2009cites this paper
• Adjuvant analgesics in neuropathic pain

  2009cites this paper
• Is there a therapeutic window with some antidepressants for analgesic response?

  2009cites this paper
• The Brief Pain Inventory User Guide

  2009cites this paper
• Peripheral polyneuropathy in type 2 diabetes mellitus and impaired glucose tolerance. Correlations between morphology, neurophysiology, and clinical findings

  2009cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2009cites this paper
• Neurología Argentina

  year unknowncites this paper